Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tobramycin (nebcin) (1 trial)
Chronic Disease (Phase 2)
Sinusitis (Phase 2)
Trials (1 total)
Trial APIs (1 total)